Stem cells and modeling of autism spectrum disorders

Experimental Neurology

Volumn 260, Issue , 2014, Pages 33-43

  Freitas, Beatriz C G ^a   Trujillo, Cleber A ^a   Carromeu, Cassiano ^a   Yusupova, Marianna ^a   Herai, Roberto H ^a   Muotri, Alysson R ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Angelman syndrome; Animal model; Autism spectrum disorders; Fragile X syndrome; Genomic editing; Induced pluripotent stem cells; Rett syndrome; Stem cells; Timothy syndrome

Indexed keywords

AUTISM; AUTOSOMAL DISORDER; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG SCREENING; FRAGILE X SYNDROME; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE ENVIRONMENT INTERACTION; HAPPY PUPPET SYNDROME; MOUSE MODEL; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PREVALENCE; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TIMOTHY SYNDROME; X CHROMOSOME INACTIVATION; ANIMAL; ANIMAL MODEL; AUTISM SPECTRUM DISORDERS; BIOLOGICAL THERAPY; CYTOLOGY; DISEASE MODEL; GENETICS; GENOMIC EDITING; HUMAN; METHODOLOGY; NERVE CELL; PHYSIOLOGY; STEM CELL;

ANGELMAN SYNDROME; ANIMAL MODEL; AUTISM SPECTRUM DISORDERS; FRAGILE X SYNDROME; GENOMIC EDITING; INDUCED PLURIPOTENT STEM CELLS; RETT SYNDROME; STEM CELLS; TIMOTHY SYNDROME;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; HUMANS; NEURONS; RETT SYNDROME; STEM CELLS;

EID: 84908372645     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.09.017     Document Type: Review

References (156)

1. A.D.A.M. Medical Encyclopedia Autism 2005, A.D.A.M., Inc., Atlanta (GA).
2. Abell F., Krams M., Ashburner J., Passingham R., Friston K., Frackowiak R., Happe F., Frith C., Frith U. The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport 1999, 10:1647-1651.
3. Amenduni M., De Filippis R., Cheung A.Y., Disciglio V., Epistolato M.C., Ariani F., Mari F., Mencarelli M.A., Hayek Y., Renieri A., Ellis J., Meloni I. iPS cells to model CDKL5-related disorders. Eur. J. Hum. Genet. 2011, 19:1246-1255.
4. American Psychiatric Association American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 2000.
5. Amiri A., Cho W., Zhou J., Birnbaum S.G., Sinton C.M., McKay R.M., Parada L.F. Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. J. Neurosci. 2012, 32:5880-5890.
6. Anagnostou E., Taylor M.J. Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here. Mol. Autism 2011, 2:4.
7. Ananiev G., Williams E.C., Li H., Chang Q. Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model. PLoS One 2011, 6:e25255.
8. Armstrong D.D. Review of Rett syndrome. J. Neuropathol. Exp. Neurol. 1997, 56:843-849.
9. Aylward E.H., Minshew N.J., Field K., Sparks B.F., Singh N. Effects of age on brain volume and head circumference in autism. Neurology 2002, 59:175-183.
10. Bailey A., Luthert P., Dean A., Harding B., Janota I., Montgomery M., Rutter M., Lantos P. A clinicopathological study of autism. Brain 1998, 121(Pt 5):889-905.
11. Beacher F.D., Radulescu E., Minati L., Baron-Cohen S., Lombardo M.V., Lai M.C., Walker A., Howard D., Gray M.A., Harrison N.A., Critchley H.D. Sex differences and autism: brain function during verbal fluency and mental rotation. PLoS One 2012, 7:e38355.
12. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J. Comp. Neurol. 2009, 514:240-258.
13. Berg J.M., Geschwind D.H. Autism genetics: searching for specificity and convergence. Genome Biol. 2012, 13:247.
14. Bibikova M., Beumer K., Trautman J.K., Carroll D. Enhancing gene targeting with designed zinc finger nucleases. Science 2003, 300:764.
15. Bosnjak Z.J. Developmental neurotoxicity screening using human embryonic stem cells. Exp. Neurol. 2012, 237:207-210.
16. Brennan F.X., Albeck D.S., Paylor R. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task. Genes Brain Behav. 2006, 5:467-471.
17. Brennand K.J., Gage F.H. Modeling psychiatric disorders through reprogramming. Dis. Model. Mech. 2012, 5:26-32.
18. Bruder, M., Kerins, G., Mazzarella, C., Sims, J., Stein, N., in press. Brief report: the medical care of adults with autism spectrum disorders: identifying the needs. J. Autism Dev. Disord. pp 2498-2504. http://dx.doi.org/10.1007/s10803-012-1496-x.
19. Brunet E., Simsek D., Tomishima M., DeKelver R., Choi V.M., Gregory P., Urnov F., Weinstock D.M., Jasin M. Chromosomal translocations induced at specified loci in human stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10620-10625.
20. Callan M.A., Clements N., Ahrendt N., Zarnescu D.C. Fragile X protein is required for inhibition of insulin signaling and regulates glial-dependent neuroblast reactivation in the developing brain. Brain Res. 2012, 1462:151-161.
21. Capecchi M.R. The new mouse genetics: altering the genome by gene targeting. Trends Genet. 1989, 5:70-76.
22. Carter J.C., Lanham D.C., Pham D., Bibat G., Naidu S., Kaufmann W.E. Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study. AJNR Am. J. Neuroradiol. 2008, 29:436-441.
23. Centers for Disease Control and Prevention Centers for Disease Control and Prevention: Autism and Developmental Disabilities Monitoring Network 2012.
24. Cermak T., Doyle E.L., Christian M., Wang L., Zhang Y., Schmidt C., Baller J.A., Somia N.V., Bogdanove A.J., Voytas D.F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011, 39:e82.
25. Chen L., Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 2001, 103:1043-1050.
26. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 2001, 27:327-331.
27. Chen S., Do J.T., Zhang Q., Yao S., Yan F., Peters E.C., Scholer H.R., Schultz P.G., Ding S. Self-renewal of embryonic stem cells by a small molecule. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17266-17271.
28. Cheung A.Y., Horvath L.M., Grafodatskaya D., Pasceri P., Weksberg R., Hotta A., Carrel L., Ellis J. Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 2011, 20:2103-2115.
29. Cook E.H., Scherer S.W. Copy-number variations associated with neuropsychiatric conditions. Nature 2008, 455:919-923.
30. Courchesne E., Yeung-Courchesne R., Press G.A., Hesselink J.R., Jernigan T.L. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N. Engl. J. Med. 1988, 318:1349-1354.
31. Courchesne E., Campbell K., Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res. 2011, 1380:138-145.
32. Courchesne E., Mouton P.R., Calhoun M.E., Semendeferi K., Ahrens-Barbeau C., Hallet M.J., Barnes C.C., Pierce K. Neuron number and size in prefrontal cortex of children with autism. JAMA 2011, 306:2001-2010.
33. Dani V.S., Nelson S.B. Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J. Neurosci. 2009, 29:11263-11270.
34. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12560-12565.
35. de Vrij F.M., Levenga J., van der Linde H.C., Koekkoek S.K., De Zeeuw C.I., Nelson D.L., Oostra B.A., Willemsen R. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol. Dis. 2008, 31:127-132.
36. DeLorey T.M., Handforth A., Anagnostaras S.G., Homanics G.E., Minassian B.A., Asatourian A., Fanselow M.S., Delgado-Escueta A., Ellison G.D., Olsen R.W. Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J. Neurosci. 1998, 18:8505-8514.
37. DeLorey T.M., Sahbaie P., Hashemi E., Homanics G.E., Clark J.D. Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav. Brain Res. 2008, 187:207-220.
38. Desbordes S.C., Placantonakis D.G., Ciro A., Socci N.D., Lee G., Djaballah H., Studer L. High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2008, 2:602-612.
39. D'Hooge R., Nagels G., Franck F., Bakker C.E., Reyniers E., Storm K., Kooy R.F., Oostra B.A., Willems P.J., De Deyn P.P. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 1997, 76:367-376.
40. Ding S., Schultz P.G. Small molecules and future regenerative medicine. Curr. Top. Med. Chem. 2005, 5:383-395.
41. Ding S., Wu T.Y., Brinker A., Peters E.C., Hur W., Gray N.S., Schultz P.G. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7632-7637.
42. Dolen G., Osterweil E., Rao B.S., Smith G.B., Auerbach B.D., Chattarji S., Bear M.F. Correction of fragile X syndrome in mice. Neuron 2007, 56:955-962.
43. D'Souza A., Onem E., Patel P., La Gamma E.F., Nankova B.B. Valproic acid regulates catecholaminergic pathways by concentration-dependent threshold effects on TH mRNA synthesis and degradation. Brain Res. 2009, 1247:1-10.
44. Ebert, A.D., Liang, P., Wu, J.C., in press. Induced pluripotent stem cells as a disease modeling and drug screening platform. J. Cardiovasc. Pharmacol. http://dx.doi.org/doi:10.1097/FJC.0b013e318247f642.
45. Ecker C., Suckling J., Deoni S.C., Lombardo M.V., Bullmore E.T., Baron-Cohen S., Catani M., Jezzard P., Barnes A., Bailey A.J., Williams S.C., Murphy D.G. Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study. Arch. Gen. Psychiatry 2012, 69:195-209.
46. Egawa N., Kitaoka S., Tsukita K., Naitoh M., Takahashi K., Yamamoto T., Adachi F., Kondo T., Okita K., Asaka I., Aoi T., Watanabe A., Yamada Y., Morizane A., Takahashi J., Ayaki T., Ito H., Yoshikawa K., Yamawaki S., Suzuki S., Watanabe D., Hioki H., Kaneko T., Makioka K., Okamoto K., Takuma H., Tamaoka A., Hasegawa K., Nonaka T., Hasegawa M., Kawata A., Yoshida M., Nakahata T., Takahashi R., Marchetto M.C., Gage F.H., Yamanaka S., Inoue H. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 2012, 4:145ra104.
47. Eiges R., Urbach A., Malcov M., Frumkin T., Schwartz T., Amit A., Yaron Y., Eden A., Yanuka O., Benvenisty N., Ben-Yosef D. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007, 1:568-577.
48. Elgersma Y., Fedorov N.B., Ikonen S., Choi E.S., Elgersma M., Carvalho O.M., Giese K.P., Silva A.J. Inhibitory autophosphorylation of CaMKII controls PSD association, plasticity, and learning. Neuron 2002, 36:493-505.
49. Engler C., Gruetzner R., Kandzia R., Marillonnet S. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS One 2009, 4:e5553.
50. Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., Warren S.T. Translational suppression by trinucleotide repeat expansion at FMR1. Science 1995, 268:731-734.
51. Fogel B.L., Wexler E., Wahnich A., Friedrich T., Vijayendran C., Gao F., Parikshak N., Konopka G., Geschwind D.H. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 2012, 21:4171-4186. http://dx.doi.org/10.1093/hmg/dds240.
52. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 2005, 66(Suppl. 10):3-8.
53. Freitag C.M., Staal W., Klauck S.M., Duketis E., Waltes R. Genetics of autistic disorders: review and clinical implications. Eur. Child Adolesc. Psychiatry 2010, 19:169-178.
54. Garber K. Neuroscience. Autism's cause may reside in abnormalities at the synapse. Science 2007, 317:190-191.
55. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., Imielinski M., Frackelton E.C., Reichert J., Crawford E.L., Munson J., Sleiman P.M., Chiavacci R., Annaiah K., Thomas K., Hou C., Glaberson W., Flory J., Otieno F., Garris M., Soorya L., Klei L., Piven J., Meyer K.J., Anagnostou E., Sakurai T., Game R.M., Rudd D.S., Zurawiecki D., McDougle C.J., Davis L.K., Miller J., Posey D.J., Michaels S., Kolevzon A., Silverman J.M., Bernier R., Levy S.E., Schultz R.T., Dawson G., Owley T., McMahon W.M., Wassink T.H., Sweeney J.A., Nurnberger J.I., Coon H., Sutcliffe J.S., Minshew N.J., Grant S.F., Bucan M., Cook E.H., Buxbaum J.D., Devlin B., Schellenberg G.D., Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
56. Goines, P.E., Ashwood, P., in press. Cytokine dysregulation in autism spectrum disorders Q13 (ASD): possible role of the environment. Neurotoxicol. Teratol. http://dx.doi.org/10.1016/j.ntt.2012.07.006.
57. Greer P.L., Hanayama R., Bloodgood B.L., Mardinly A.R., Lipton D.M., Flavell S.W., Kim T.K., Griffith E.C., Waldon Z., Maehr R., Ploegh H.L., Chowdhury S., Worley P.F., Steen J., Greenberg M.E. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 2010, 140:704-716.
58. Guy J., Hendrich B., Holmes M., Martin J.E., Bird A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet. 2001, 27:322-326.
59. Guy J., Gan J., Selfridge J., Cobb S., Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 2007, 315:1143-1147.
60. Han S.S., Williams L.A., Eggan K.C. Constructing and deconstructing stem cell models of neurological disease. Neuron 2011, 70:626-644.
61. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
62. Hockemeyer D., Jaenisch R. Gene targeting in human pluripotent cells. Cold Spring Harb. Symp. Quant. Biol. 2010, 75:201-209.
63. Hockemeyer D., Soldner F., Beard C., Gao Q., Mitalipova M., DeKelver R.C., Katibah G.E., Amora R., Boydston E.A., Zeitler B., Meng X., Miller J.C., Zhang L., Rebar E.J., Gregory P.D., Urnov F.D., Jaenisch R. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 2009, 27:851-857.
64. Hockemeyer D., Wang H., Kiani S., Lai C.S., Gao Q., Cassady J.P., Cost G.J., Zhang L., Santiago Y., Miller J.C., Zeitler B., Cherone J.M., Meng X., Hinkley S.J., Rebar E.J., Gregory P.D., Urnov F.D., Jaenisch R. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 2011, 29:731-734.
65. Homanics G.E., DeLorey T.M., Firestone L.L., Quinlan J.J., Handforth A., Harrison N.L., Krasowski M.D., Rick C.E., Korpi E.R., Makela R., Brilliant M.H., Hagiwara N., Ferguson C., Snyder K., Olsen R.W. Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4143-4148.
66. Hotta A., Cheung A.Y., Farra N., Vijayaragavan K., Seguin C.A., Draper J.S., Pasceri P., Maksakova I.A., Mager D.L., Rossant J., Bhatia M., Ellis J. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat. Methods 2009, 6:370-376.
67. Hsu M., Yeung-Courchesne R., Courchesne E., Press G.A. Absence of magnetic resonance imaging evidence of pontine abnormality in infantile autism. Arch. Neurol. 1991, 48:1160-1163.
68. Hussein S.M., Batada N.N., Vuoristo S., Ching R.W., Autio R., Narva E., Ng S., Sourour M., Hamalainen R., Olsson C., Lundin K., Mikkola M., Trokovic R., Peitz M., Brustle O., Bazett-Jones D.P., Alitalo K., Lahesmaa R., Nagy A., Otonkoski T. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471:58-62.
69. Irwin S.A., Galvez R., Greenough W.T. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex 2000, 10:1038-1044.
70. Jentarra G.M., Olfers S.L., Rice S.G., Srivastava N., Homanics G.E., Blue M., Naidu S., Narayanan V. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci. 2010, 11:19.
71. Jiang Y.H., Armstrong D., Albrecht U., Atkins C.M., Noebels J.L., Eichele G., Sweatt J.D., Beaudet A.L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 1998, 21:799-811.
72. Kay S., Hahn S., Marois E., Hause G., Bonas U. A bacterial effector acts as a plant transcription factor and induces a cell size regulator. Science 2007, 318:648-651.
73. Kelleher R.J., Geigenmuller U., Hovhannisyan H., Trautman E., Pinard R., Rathmell B., Carpenter R., Margulies D. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS One 2012, 7:e35003.
74. Kemper T.L., Bauman M. Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 1998, 57:645-652.
75. Kim K.Y., Hysolli E., Park I.H. Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14169-14174.
76. Kindler S., Kreienkamp H.J. The role of the postsynaptic density in the pathology of the fragile X syndrome. Results Probl. Cell Differ. 2012, 54:61-80.
77. King M., Bearman P. Diagnostic change and the increased prevalence of autism. Int. J. Epidemiol. 2009, 38:1224-1234.
78. Knight D., Xie W., Boulianne G.L. Neurexins and neuroligins: recent insights from invertebrates. Mol. Neurobiol. 2011, 44:426-440.
79. Koenen K.C., Moffitt T.E., Roberts A.L., Martin L.T., Kubzansky L., Harrington H., Poulton R., Caspi A. Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am. J. Psychiatry 2009, 166:50-57.
80. Kogan M.D., Strickland B.B., Blumberg S.J., Singh G.K., Perrin J.M., van Dyck P.C. A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006. Pediatrics 2008, 122:e1149-e1158.
81. Kogan M.D., Blumberg S.J., Schieve L.A., Boyle C.A., Perrin J.M., Ghandour R.M., Singh G.K., Strickland B.B., Trevathan E., van Dyck P.C. Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics 2009, 124:1395-1403.
82. Konopka G., Wexler E., Rosen E., Mukamel Z., Osborn G.E., Chen L., Lu D., Gao F., Gao K., Lowe J.K., Geschwind D.H. Modeling the functional genomics of autism using human neurons. Mol. Psychiatry 2012, 17:202-214.
83. Lengner C.J. iPS cell technology in regenerative medicine. Ann. N. Y. Acad. Sci. 2010, 1192:38-44.
84. Lin M., Pedrosa E., Shah A., Hrabovsky A., Maqbool S., Zheng D., Lachman H.M. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One 2011, 6:e23356.
85. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., Mandel G. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
86. Liu Z.H., Smith C.B. Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome. Neurosci. Lett. 2009, 454:62-66.
87. Liu J., Koscielska K.A., Cao Z., Hulsizer S., Grace N., Mitchell G., Nacey C., Githinji J., McGee J., Garcia-Arocena D., Hagerman R.J., Nolta J., Pessah I.N., Hagerman P.J. Signaling defects in iPSC-derived fragile X premutation neurons. Hum. Mol. Genet. 2012, 21:3795-3805.
88. Lombardo A., Genovese P., Beausejour C.M., Colleoni S., Lee Y.L., Kim K.A., Ando D., Urnov F.D., Galli C., Gregory P.D., Holmes M.C., Naldini L. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 2007, 25:1298-1306.
89. Lotspeich L.J., Kwon H., Schumann C.M., Fryer S.L., Goodlin-Jones B.L., Buonocore M.H., Lammers C.R., Amaral D.G., Reiss A.L. Investigation of neuroanatomical differences between autism and Asperger syndrome. Arch. Gen. Psychiatry 2004, 61:291-298.
90. Lubs H.A., Stevenson R.E., Schwartz C.E. Fragile X and X-linked intellectual disability: four decades of discovery. Am. J. Hum. Genet. 2012, 90:579-590.
91. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
92. Marchetto M.C., Brennand K.J., Boyer L.F., Gage F.H. Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum. Mol. Genet. 2011, 20:R109-R115.
93. Margulies, D.M. (N., MA, US), Bear, Mark Firman (Boston, MA, US), 07/07/2011. Compositions and Methods for Diagnosing Autism Spectrum Disorders.
94. McAlonan G.M., Cheung V., Cheung C., Suckling J., Lam G.Y., Tai K.S., Yip L., Murphy D.G., Chua S.E. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 2005, 128:268-276.
95. McNaughton C.H., Moon J., Strawderman M.S., Maclean K.N., Evans J., Strupp B.J. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav. Neurosci. 2008, 122:293-300.
96. Mekhoubad S., Bock C., de Boer A.S., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 2012, 10:595-609.
97. Mendelsohn N.J., Schaefer G.B. Genetic evaluation of autism. Semin. Pediatr. Neurol. 2008, 15:27-31.
98. Miller J.C., Tan S., Qiao G., Barlow K.A., Wang J., Xia D.F., Meng X., Paschon D.E., Leung E., Hinkley S.J., Dulay G.P., Hua K.L., Ankoudinova I., Cost G.J., Urnov F.D., Zhang H.S., Holmes M.C., Zhang L., Gregory P.D., Rebar E.J. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 2011, 29:143-148.
99. Mineur Y.S., Sluyter F., de Wit S., Oostra B.A., Crusio W.E. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 2002, 12:39-46.
100. Mineur Y.S., Huynh L.X., Crusio W.E. Social behavior deficits in the Fmr1 mutant mouse. Behav. Brain Res. 2006, 168:172-175.
101. Miura K., Kishino T., Li E., Webber H., Dikkes P., Holmes G.L., Wagstaff J. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 2002, 9:149-159.
102. Moretti P., Bouwknecht J.A., Teague R., Paylor R., Zoghbi H.Y. Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 2005, 14:205-220.
103. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Teague R., Antalffy B., Armstrong D., Arancio O., Sweatt J.D., Zoghbi H.Y. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci. 2006, 26:319-327.
104. Morgan J.T., Chana G., Abramson I., Semendeferi K., Courchesne E., Everall I.P. Abnormal microglial-neuronal spatial organization in the dorsolateral prefrontal cortex in autism. Brain Res. 2012, 1456:72-81.
105. Moy S.S., Nadler J.J. Advances in behavioral genetics: mouse models of autism. Mol. Psychiatry 2008, 13:4-26.
106. Muotri A.R., Marchetto M.C., Coufal N.G., Oefner R., Yeo G., Nakashima K., Gage F.H. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468:443-446.
107. Murakami J.W., Courchesne E., Haas R.H., Press G.A., Yeung-Courchesne R. Cerebellar and cerebral abnormalities in Rett syndrome: a quantitative MR analysis. AJR Am. J. Roentgenol. 1992, 159:177-183.
108. Mussolino C., Morbitzer R., Lutge F., Dannemann N., Lahaye T., Cathomen T. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res. 2011, 39:9283-9293.
109. Musumeci S.A., Bosco P., Calabrese G., Bakker C., De Sarro G.B., Elia M., Ferri R., Oostra B.A. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 2000, 41:19-23.
110. Nosyreva E.D., Huber K.M. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J. Neurophysiol. 2006, 95:3291-3295.
111. O'Roak B.J., Deriziotis P., Lee C., Vives L., Schwartz J.J., Girirajan S., Karakoc E., Mackenzie A.P., Ng S.B., Baker C., Rieder M.J., Nickerson D.A., Bernier R., Fisher S.E., Shendure J., Eichler E.E. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat. Genet. 2011, 43:585-589.
112. Palmen S.J., van Engeland H., Hof P.R., Schmitz C. Neuropathological findings in autism. Brain 2004, 127:2572-2583.
113. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., Cord B., Palmer T.D., Chikahisa S., Nishino S., Bernstein J.A., Hallmayer J., Geschwind D.H., Dolmetsch R.E. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 2011, 17:1657-1662.
114. Pelka G.J., Watson C.M., Radziewic T., Hayward M., Lahooti H., Christodoulou J., Tam P.P. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain 2006, 129:887-898.
115. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., Almeida J., Bacchelli E., Bader G.D., Bailey A.J., Baird G., Battaglia A., Berney T., Bolshakova N., Bolte S., Bolton P.F., Bourgeron T., Brennan S., Brian J., Bryson S.E., Carson A.R., Casallo G., Casey J., Chung B.H., Cochrane L., Corsello C., Crawford E.L., Crossett A., Cytrynbaum C., Dawson G., de Jonge M., Delorme R., Drmic I., Duketis E., Duque F., Estes A., Farrar P., Fernandez B.A., Folstein S.E., Fombonne E., Freitag C.M., Gilbert J., Gillberg C., Glessner J.T., Goldberg J., Green A., Green J., Guter S.J., Hakonarson H., Heron E.A., Hill M., Holt R., Howe J.L., Hughes G., Hus V., Igliozzi R., Kim C., Klauck S.M., Kolevzon A., Korvatska O., Kustanovich V., Lajonchere C.M., Lamb J.A., Laskawiec M., Leboyer M., Le Couteur A., Leventhal B.L., Lionel A.C., Liu X.Q., Lord C., Lotspeich L., Lund S.C., Maestrini E., Mahoney W., Mantoulan C., Marshall C.R., McConachie H., McDougle C.J., McGrath J., McMahon W.M., Merikangas A., Migita O., Minshew N.J., Mirza G.K., Munson J., Nelson S.F., Noakes C., Noor A., Nygren G., Oliveira G., Papanikolaou K., Parr J.R., Parrini B., Paton T., Pickles A., Pilorge M., Piven J., Ponting C.P., Posey D.J., Poustka A., Poustka F., Prasad A., Ragoussis J., Renshaw K., Rickaby J., Roberts W., Roeder K., Roge B., Rutter M.L., Bierut L.J., Rice J.P., Salt J., Sansom K., Sato D., Segurado R., Sequeira A.F., Senman L., Shah N., Sheffield V.C., Soorya L., Sousa I., Stein O., Sykes N., Stoppioni V., Strawbridge C., Tancredi R., Tansey K., Thiruvahindrapduram B., Thompson A.P., Thomson S., Tryfon A., Tsiantis J., Van Engeland H., Vincent J.B., Volkmar F., Wallace S., Wang K., Wang Z., Wassink T.H., Webber C., Weksberg R., Wing K., Wittemeyer K., Wood S., Wu J., Yaspan B.L., Zurawiecki D., Zwaigenbaum L., Buxbaum J.D., Cantor R.M., Cook E.H., Coon H., Cuccaro M.L., Devlin B., Ennis S., Gallagher L., Geschwind D.H., Gill M., Haines J.L., Hallmayer J., Miller J., Monaco A.P., Nurnberger J.I., Paterson A.D., Pericak-Vance M.A., Schellenberg G.D., Szatmari P., Vicente A.M., Vieland V.J., Wijsman E.M., Scherer S.W., Sutcliffe J.S., Betancur C. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
116. Piven J., Nehme E., Simon J., Barta P., Pearlson G., Folstein S.E. Magnetic resonance imaging in autism: measurement of the cerebellum, pons, and fourth ventricle. Biol. Psychiatry 1992, 31:491-504.
117. Porteus M.H., Carroll D. Gene targeting using zinc finger nucleases. Nat. Biotechnol. 2005, 23:967-973.
118. Qiu L.F., Lu T.J., Hu X.L., Yi Y.H., Liao W.P., Xiong Z.Q. Limbic epileptogenesis in a mouse model of fragile X syndrome. Cereb. Cortex 2009, 19:1504-1514.
119. Rakic P. Evolution of the neocortex: a perspective from developmental biology. Nat. Rev. Neurosci. 2009, 10:724-735.
120. Reiss A.L. Childhood developmental disorders: an academic and clinical convergence point for psychiatry, neurology, psychology and pediatrics. J. Child Psychol. Psychiatry 2009, 50:87-98.
121. Ricciardi S., Ungaro F., Hambrock M., Rademacher N., Stefanelli G., Brambilla D., Sessa A., Magagnotti C., Bachi A., Giarda E., Verpelli C., Kilstrup-Nielsen C., Sala C., Kalscheuer V.M., Broccoli V. CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat. Cell Biol. 2012, 14:911-923.
122. Rossignol D.A., Frye R.E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 2012, 17:290-314.
123. Saitoh O., Karns C.M., Courchesne E. Development of the hippocampal formation from 2 to 42years: MRI evidence of smaller area dentata in autism. Brain 2001, 124:1317-1324.
124. Sanders S.J., Murtha M.T., Gupta A.R., Murdoch J.D., Raubeson M.J., Willsey A.J., Ercan-Sencicek A.G., DiLullo N.M., Parikshak N.N., Stein J.L., Walker M.F., Ober G.T., Teran N.A., Song Y., El-Fishawy P., Murtha R.C., Choi M., Overton J.D., Bjornson R.D., Carriero N.J., Meyer K.A., Bilguvar K., Mane S.M., Sestan N., Lifton R.P., Gunel M., Roeder K., Geschwind D.H., Devlin B., State M.W. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
125. Sato M., Racine R.J., McIntyre D.C. Kindling: basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol. 1990, 76:459-472.
126. Schanen C., Francke U. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map. Am. J. Hum. Genet. 1998, 63:267-269.
127. Scholze H., Boch J. TAL effector-DNA specificity. Virulence 2010, 1:428-432.
128. Schumann C.M., Hamstra J., Goodlin-Jones B.L., Lotspeich L.J., Kwon H., Buonocore M.H., Lammers C.R., Reiss A.L., Amaral D.G. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J. Neurosci. 2004, 24:6392-6401.
129. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., Leotta A., Pai D., Zhang R., Lee Y.H., Hicks J., Spence S.J., Lee A.T., Puura K., Lehtimaki T., Ledbetter D., Gregersen P.K., Bregman J., Sutcliffe J.S., Jobanputra V., Chung W., Warburton D., King M.C., Skuse D., Geschwind D.H., Gilliam T.C., Ye K., Wigler M. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
130. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
131. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
132. Spencer C.M., Alekseyenko O., Serysheva E., Yuva-Paylor L.A., Paylor R. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav. 2005, 4:420-430.
133. Spencer C.M., Alekseyenko O., Hamilton S.M., Thomas A.M., Serysheva E., Yuva-Paylor L.A., Paylor R. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res. 2011, 4:40-56.
134. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., Keating M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119:19-31.
135. Stigler K.A., McDonald B.C., Anand A., Saykin A.J., McDougle C.J. Structural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res. 2011, 1380:146-161.
136. Sugimoto Y., Konig J., Hussain S., Zupan B., Curk T., Frye M., Ule J. Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions. Genome Biol. 2012, 13:R67.
137. Summers K.M. Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases. Hum. Mutat. 1996, 7:283-293.
138. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
139. Tate P., Skarnes W., Bird A. The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse. Nat. Genet. 1996, 12:205-208.
140. The Dutch-Belgian Fragile X Consortium Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 1994, 78:23-33.
141. Tong C., Huang G., Ashton C., Wu H., Yan H., Ying Q.L. Rapid and cost-effective gene targeting in rat embryonic stem cells by TALENs. J. Genet. Genomics 2012, 39:275-280.
142. Underhill G.H., Bhatia S.N. High-throughput analysis of signals regulating stem cell fate and function. Curr. Opin. Chem. Biol. 2007, 11:357-366.
143. Urbach A., Bar-Nur O., Daley G.Q., Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6:407-411.
144. van Woerden G.M., Harris K.D., Hojjati M.R., Gustin R.M., Qiu S., de Avila Freire R., Jiang Y.H., Elgersma Y., Weeber E.J. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat. Neurosci. 2007, 10:280-282.
145. Veltman M.W., Craig E.E., Bolton P.F. Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review. Psychiatr. Genet. 2005, 15:243-254.
146. Ventura R., Pascucci T., Catania M.V., Musumeci S.A., Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav. Pharmacol. 2004, 15:433-442.
147. Villard L., Kpebe A., Cardoso C., Chelly P.J., Tardieu P.M., Fontes M. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology 2000, 55:1188-1193.
148. Volkmar F.R., Wiesner L.A. A pratical guide to autism: what every parent, family member and teacher needs to know. E-book 2009, 384 pages. (ISBN: 978-0-470-50261-7).
149. Wallace M.L., Burette A.C., Weinberg R.J., Philpot B.D. Maternal loss of Ube3a produces an excitatory/inhibitory imbalance through neuron type-specific synaptic defects. Neuron 2012, 74:793-800.
150. Willemsen M.H., Valles A., Kirkels L.A., Mastebroek M., Olde Loohuis N., Kos A., Wissink-Lindhout W.M., de Brouwer A.P., Nillesen W.M., Pfundt R., Holder-Espinasse M., Vallee L., Andrieux J., Coppens-Hofman M.C., Rensen H., Hamel B.C., van Bokhoven H., Aschrafi A., Kleefstra T. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J. Med. Genet. 2011, 48:810-818.
151. Wong E.L., Wong S.Y., Lee N., Cheung A., Griffiths S. Healthcare workers' duty concerns of working in the isolation ward during the novel H1N1 pandemic. J. Clin. Nurs. 2012, 21:1466-1475.
152. Wynder C., Stalker L., Doughty M.L. Role of H3K4 demethylases in complex neurodevelopmental diseases. Epigenomics 2010, 2:407-418.
153. Yashiro K., Riday T.T., Condon K.H., Roberts A.C., Bernardo D.R., Prakash R., Weinberg R.J., Ehlers M.D., Philpot B.D. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 2009, 12:777-783.
154. Yu K.K., Cheung C., Chua S.E., McAlonan G.M. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J. Psychiatry Neurosci. 2011, 36:412-421.
155. Zhang A., Shen C.H., Ma S.Y., Ke Y., El Idrissi A. Altered expression of Autism-associated genes in the brain of Fragile X mouse model. Biochem. Biophys. Res. Commun. 2009, 379:920-923.
156. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., Porteus M.H., Joung J.K., Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009, 5:97-110.